Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside

Current Research in Pharmacology and Drug Discovery(2021)10.1016/j.crphar.2021.100045Source: DataRank Database

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside is a research paper published in Current Research in Pharmacology and Drug Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.48)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Keivan Zandi ORCID,Leda Bassit ORCID,Yee Tsuey Ong ORCID,Kiran Verma ORCID,Peng Liu ORCID

Live enrichment

PubMed:34870151 PMC:PMC8357487 OpenAlex:https://openalex.org/W3196286946

NIAID

Grant: P30-AI-050409

NIAID

Grant: R01-AI-121315

NIAID

Grant: R01-AI-141327

NIAID NIH HHS

Grant: R01 AI121315

NIAID NIH HHS

Grant: R01 AI141327

NIAID NIH HHS

Grant: P30 AI050409

National Institutes of Health

Grant: 5R01AI141327-07

Structural and Chemical Analysis of Highly Potent ALLINI Platform

National Institutes of Health

Grant: 5R01AI121315-06

Taking aim at HBV eradication using novel NRTIs and Capsid effectors

National Institutes of Health

Grant: 5P30AI050409-20

Center for AIDS Research at Emory University

National Institutes of Health

FWCI

1.48

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.crphar.2021.100045

publisherhttps://doi.org/10.1016/j.crphar.2021.100045

publisherhttps://api.elsevier.com/content/article/PII:S2590257121000328?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590257121000328?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34870151

Fields of Study

COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Vero cellIntracellularVirologyPotencyProdrugNucleosideVirusChemistryBiologyPharmacologyBiochemistryIn vitroCoronavirusAntiviral AgentsHcov-oc43Who, World Health OrganizationNtp, Nucleoside TriphosphateAce2, Angiotensin-converting Enzyme 2Gs-441524RemdesivirCata, Cathepsin ACovid-19Ces1, Carboxylesterase 1Dp, DiphosphateHae, Human Airway EpithelialHint1, Histidine Triad Nucleotide-binding Protein 1Mp, MonophosphateTp, TriphosphateIcsars-cov-2-mng, Sars-cov-2 Infectious Clone Virus Containing Mneongreen ReporterCovid-19, Coronavirus Disease 2019Sars-cov-2, Severe Acute Respiratory Syndrome Coronavirus 2Anti-sars-cov-2COVID-19 therapyTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside

FAIR Checklist

Authors (15)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)